keyword
MENU ▼
Read by QxMD icon Read
search

esophageal squamous cell carcinoma

keyword
https://www.readbyqxmd.com/read/29440931/influential-factors-on-radiotherapy-efficacy-and-prognosis-in-patients-with-secondary-lymph-node-metastasis-after-esophagectomy-of-thoracic-esophageal-squamous-cell-carcinoma
#1
Shao-Bing Zhou, Xin-Wei Guo, Liang Gu, Sheng-Jun Ji
Background: The purpose of this study was to clarify whether pretreatment tumor burden-related index, including the gross tumor volume (GTV) of metastatic lymph nodes (V LN ) and maximum diameter of metastatic lymph nodes (D LN ), and inflammatory markers, consisting of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), are useful for assessing the therapeutic effects and prognosis with secondary lymph node metastasis (LNM) receiving chemoradiotherapy (CRT) or radiotherapy (RT) alone after resection of esophageal squamous cell carcinoma (ESCC)...
2018: Cancer Management and Research
https://www.readbyqxmd.com/read/29436634/capsaicin-inhibits-glycolysis-in-esophageal-squamous-cell-carcinoma-by-regulating-hexokinase%C3%A2-2-expression
#2
Xinli Mao, Hongyuan Zhu, Dinghai Luo, Liping Ye, Huifei Yin, Jinshun Zhang, Yan Zhang, Yu Zhang
Capsaicin is a principal component of hot red peppers and chili peppers. Previous studies have reported that capsaicin exhibits antitumor functions in a variety of tumor models. Although various mechanisms underlying the capsaicin‑mediated inhibition of tumor growth have been demonstrated, the impact of capsaicin on tumor metabolism has rarely been reported. The present study demonstrated that capsaicin exhibited an inhibitory effect on tumor glycolysis in esophageal squamous cell carcinoma (ESCC) cells. Following treatment with capsaicin, glucose consumption and lactate production in ESCC cells was decreased...
February 8, 2018: Molecular Medicine Reports
https://www.readbyqxmd.com/read/29435906/retrospective-assessment-of-the-diagnostic-accuracy-of-the-depth-of-invasion-by-narrow-band-imaging-magnifying-endoscopy-in-patients-with-superficial-esophageal-squamous-cell-carcinoma
#3
Chikatoshi Katada, Satoshi Tanabe, Takuya Wada, Kenji Ishido, Takafumi Yano, Yasuaki Furue, Yuki Kondo, Natsuko Kawanishi, Sakiko Yamane, Akinori Watanabe, Mizutomo Azuma, Wasaburo Koizumi
PURPOSE: Treatment strategies for superficial esophageal squamous cell carcinoma (S-ESCC) are determined mainly on the basis of the depth of invasion. We retrospectively studied the accuracy of the depth of tumor invasion, comprehensively assessed using the Japan Esophageal Society (JES) classification. METHODS: The study group comprised 256 patients who underwent narrow band imaging (NBI) magnifying endoscopy, and endoscopic submucosal dissection for S-ESCC. The depth of invasion of S-ESCC was classified into three groups: EP/LPM, MM/SM1, and SM2...
February 13, 2018: Journal of Gastrointestinal Cancer
https://www.readbyqxmd.com/read/29435305/clinical-significance-of-the-c-reactive-protein-to-albumin-ratio-for-the-prognosis-of-patients-with-esophageal-squamous-cell-carcinoma
#4
Masaki Kunizaki, Tetsuro Tominaga, Kouki Wakata, Takuro Miyazaki, Keitaro Matsumoto, Yorihisa Sumida, Shigekazu Hidaka, Takuya Yamasaki, Toru Yasutake, Terumitu Sawai, Ryuji Hamamoto, Atsushi Nanashima, Takeshi Nagayasu
The aim of the present study was to investigate the prognostic value of the C-reactive protein-to-albumin ratio (CAR) and compare it with other inflammation-based prognostic scores (Glasgow prognostic score, modified Glasgow prognostic score, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, prognostic nutritional index and prognostic index) in patients with esophageal squamous cell cancer (ESCC). A database of 116 patients with primary ESCC who underwent treatment at the Division of Surgical Oncology at Nagasaki University Hospital between January 2007 and August 2014 was retrospectively reviewed and the correlations between CAR and overall survival (OS) were investigated...
February 2018: Molecular and Clinical Oncology
https://www.readbyqxmd.com/read/29435301/traditional-and-cumulative-meta-analysis-chemoradiotherapy-followed-by-surgery-versus-surgery-alone-for-resectable-esophageal-carcinoma
#5
Haiming Feng, Ye Zhao, Tao Jing, Jianxing Ma, Yinglu Zhao, Jianhua Zhang, Cheng Wang, Bin Li
The role of neoadjuvant chemoradiotherapy followed by surgery (CRTS) compared with surgery alone (SA) for resectable esophageal carcinoma has been established by several randomized controlled trials (RCTs). The present study aimed to investigate the difference in survival between the two treatments by a review of meta-analyses. Related research indicators were extracted from RCTs investigating CRTS or SA for resectable esophageal carcinoma by searching electronic databases for eligible articles. Outcomes were synthesized by adopting a fixed- or random-effects model with 95% confidence interval (CI)...
February 2018: Molecular and Clinical Oncology
https://www.readbyqxmd.com/read/29435289/outcomes-of-abdominal-esophageal-cancer-patients-who-were-treated-with-esophagectomy
#6
Hiroyuki Kitagawa, Tsutomu Namikawa, Jun Iwabu, Kazune Fujisawa, Michiya Kobayashi, Kazuhiro Hanazaki
The aim of the present study was to elucidate the characteristics and outcomes of abdominal esophageal cancer patients who were treated with esophagectomy. The records of 210 esophagectomy patients were retrospectively reviewed and the differences in postoperative outcomes and disease-specific survival between squamous cell carcinoma and adenocarcinoma were evaluated. Of the 20 abdominal esophageal cancer patients, 11 had squamous cell carcinoma, 8 had adenocarcinoma and 1 had adenosquamous cell carcinoma. The body mass index and serum albumin levels were significantly lower in the squamous cell carcinoma patients compared with those in the adenocarcinoma patients, and abdominal lymph node metastasis was significantly more frequent in the adenocarcinoma patients...
February 2018: Molecular and Clinical Oncology
https://www.readbyqxmd.com/read/29435069/serum-microrna-193b-as-a-promising-biomarker-for-prediction-of-chemoradiation-sensitivity-in-esophageal-squamous-cell-carcinoma-patients
#7
Chung Man Chan, Kenneth K Y Lai, Enders K O Ng, Mei Na Kiang, Tiffany W H Kwok, Hector K Wang, Kwok Wah Chan, Tsz Ting Law, Daniel K Tong, Kin Tak Chan, Nikki P Lee, Simon Law
Esophageal squamous cell carcinoma (ESCC) is the most predominantly occurring type of esophageal cancer worldwide. Locally advanced ESCC patients are treated by neoadjuvant chemoradiation for tumor downstaging prior to tumor resection. Patients receiving this treatment have an increased expectation of cure via the following tumor resection and have better survival outcomes. However, not all patients respond well to chemoradiation and poor responders suffer from treatment-associated toxicity and complications without benefits...
March 2018: Oncology Letters
https://www.readbyqxmd.com/read/29435043/wnt3a-expression-is-associated-with-poor-prognosis-of-esophageal-squamous-cell-carcinoma
#8
Junya Oguma, Soji Ozawa, Akihito Kazuno, Miho Nitta, Yamato Ninomiya, Hiroshi Kajiwara
The Wnt signaling pathway is widely implicated in various types of cancer. Canonical Wnt signaling, including Wnt3a, may be a key component of cancer progression or chemoresistance. Consequently, it was hypothesized that Wnt3a expression may be a prognostic factor of esophageal squamous cell carcinoma (ESCC) due to its roles in chemoresistance and tumor progression. The aim of the present study was to investigate the association between Wnt3a expression and prognosis in patients with ESCC. Wnt3a expression was evaluated in resected specimens from 139 patients with thoracic ESCC who were subjected to curative surgery without neoadjuvant therapy in Tokai University Hospital between 2007 and 2009...
March 2018: Oncology Letters
https://www.readbyqxmd.com/read/29435035/expression-of-proteins-associated-with-epithelial-mesenchymal-transition-in-esophageal-squamous-cell-carcinoma
#9
Tian Zhang, Hao Li, Yang Zhang, Pei Wang, Huijie Bian, Zhi-Nan Chen
Cluster of differentiation 147 (CD147), pituitary tumor transforming gene (PTTG) and CD44v6 are proteins involved in the epithelial-mesenchymal transition (EMT). To investigate the prognostic value of CD147 and PTTG, and CD44v6 expression in esophageal squamous cell carcinoma (ESCC), tissue microarray specimens from 76 patients with ESCC were evaluated by immunohistochemistry staining and scored by intensity and proportion of positive areas. Expression levels of CD147, PTTG and CD44v6 were higher in tumor tissues than in matched adjacent tissues...
March 2018: Oncology Letters
https://www.readbyqxmd.com/read/29435022/metformin-inhibits-the-migration-and-invasion-of-esophageal-squamous-cell-carcinoma-cells-by-downregulating-the-protein-kinase-b-signaling-pathway
#10
Yindi He, Xiaojun Tan, Hui Hu, Qinjia Wang, Xi Hu, Xianbin Cai, Yinghong Guan, Binming Chen, Xubin Jing
Previous studies have suggested that metformin, a biguanide family member widely used as an oral antidiabetic drug, may inhibit proliferation and induce apoptosis in certain types of cancer cell. However, the molecular mechanisms underlying metformin-associated anticancer effects, and in particular antimetastatic effects, remain to be fully understood. The present study assessed the efficacy of metformin in inhibiting the migration and invasion of the esophageal carcinoma cell line EC109, and evaluated the effect of metformin on the protein kinase B (AKT) signaling pathway...
March 2018: Oncology Letters
https://www.readbyqxmd.com/read/29434977/neddylation-inhibitor-mln4924-induces-g2-cell-cycle-arrest-dna-damage-and-sensitizes-esophageal-squamous-cell-carcinoma-cells-to-cisplatin
#11
Shan Lin, Zhaoyang Shang, Shuo Li, Peng Gao, Yi Zhang, Shuaiheng Hou, Peng Qin, Ziming Dong, Tao Hu, Ping Chen
Inhibiting the protein neddylation pathway using the NEDD8-activating enzyme inhibitor MLN4924 represents an attractive anticancer strategy having been demonstrated to exhibit promising anticancer efficacy and with tolerable levels of toxicity; however, the mechanism by which MLN4924 inhibits cell proliferation in human esophageal squamous cell carcinoma (ESCC) cells requires further investigation. The present study revealed that MLN4924 treatment led to G2 cell cycle arrest and enhanced the protein stability of Wee1-like protein kinase and cyclin dependent protein kinase inhibitor 1A and B and p27...
February 2018: Oncology Letters
https://www.readbyqxmd.com/read/29434888/axl-is-a-marker-for-epithelial-mesenchymal-transition-in-esophageal-squamous-cell-carcinoma
#12
Guoan Zhang, Xia Kong, Meng Wang, Hongli Zhao, Sha Han, Ronghang Hu, Jian Huang, Wen Cui
Esophageal squamous cell carcinoma (ESCC) is a common cancer in China and certain other parts of the world with a dismal prognosis for affected patients. AXL is a member of the TYRO3-AXL-MER family of receptor tyrosine kinases, and has been revealed to be an important mediator of epithelial-mesenchymal transition (EMT) in several types of cancer. However, to the best of our knowledge, its function in EMT in ESCC cells has not yet been examined. The present study employed two independent ESCC mRNA profile datasets and revealed that AXL is associated with several EMT markers...
February 2018: Oncology Letters
https://www.readbyqxmd.com/read/29434881/18f-fluorodeoxyglucose-positron-emission-computed-tomography-for-monitoring-tumor-response-in-esophageal-carcinoma-treated-with-concurrent-chemoradiotherapy
#13
Peiliang Zhang, Zengyun Li, Dongqing Wang, Fuling Ma, Ran Zhang, Wanhua Liang, Mingping Sun, Zheng Fu, Xiaorong Sun
The aim of the present study was to explore the value of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in monitoring the early tumor response of esophageal squamous cell carcinoma (ESCC) treated with concurrent chemoradiotherapy (CRT). A total of 48 patients with pathologically proven ESCC were retrospectively analyzed. All patients underwent two serial 18F-FDG PET scans at baseline (pre-CRT) and 40 Gy/4 weeks of starting radiation therapy (inter-CRT). All patients received intensity-modulated radiotherapy (with a total radiation dose of 59...
February 2018: Oncology Letters
https://www.readbyqxmd.com/read/29434854/celastrus-orbiculatus-extracts-induce-cell-cycle-arrest-and-apoptosis-in-human-esophageal-squamous-carcinoma-eca-109-cells-in-vitro-via-the-pi3k-akt-mtor-signaling-pathway
#14
Feng Jin, Guang Zhu, Dan Li, Tengyang Ni, Xiaojun Dai, Haibo Wang, Jun Feng, Yayun Qian, Lin Yang, Shiyu Guo, Tadashi Hisamitsu, Yanqing Liu
Recently, Celastrus orbiculatus ethyl acetate extracts (COE) have been investigated for their anticancer effects on digestive tract tumors. However, the therapeutic effects of COE on esophageal squamous carcinoma cells (ESCC) have not been investigated. In the present study, the effects of COE on the cell cycle and apoptosis of ESCCs were assessed in vitro, and it was revealed that COE treatment triggered G0/G1 cell cycle arrest, and induced DNA damage and apoptosis in a dose-dependent manner in ESCC. Activation of the phosphatidylinositol 3-kinase/protein kinase-B/mechanistic target of rapamycin (mTOR) pathway was also suppressed by COE...
February 2018: Oncology Letters
https://www.readbyqxmd.com/read/29434851/bufadienolides-induce-p53-mediated-apoptosis-in-esophageal-squamous-cell-carcinoma-cells-in-vitro-and-in-vivo
#15
Shaohuan Lin, Junhong Lv, Panli Peng, Changqing Cai, Jianming Deng, Haihong Deng, Xuejun Li, Xinyue Tang
Bufadienolides are a type of cardiotonic steroids isolated from the skin and parotid venom glands of the toad Bufo bufo gargarizans Cantor, and exhibit wide-spectrum anticancer activities. However, the effects and mechanisms of bufadienolides on esophageal squamous cell carcinoma (ESCC) cells remain unknown. In the present study, the anticancer activities of two bufadienolides, bufotalin and bufalin, were examined in vitro and in vivo. The results demonstrated that bufotalin and bufalin effectively inhibited the viability of ESCC cells, with half-maximal inhibitory concentration (IC50) values of 0...
February 2018: Oncology Letters
https://www.readbyqxmd.com/read/29434701/hipk2-inhibits-cell-metastasis-and-improves-chemosensitivity-in-esophageal-squamous-cell-carcinoma
#16
Zhen Zhang, Penghai Wen, Fangfang Li, Chuanshan Yao, Tongfu Wang, Bing Liang, Qingle Yang, Lei Ma, Limin He
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive and lethal malignancies worldwide. At present, the underlying mechanisms of ESCC development and progression are poorly understood. Previous studies have demonstrated that homeodomain-interacting protein kinase-2 (HIPK2) serves an important role in cancer biology, particularly in proliferation and metastasis. However, the role of HIPK2 in ESCC cells remains unclear. In the current study, the expression of HIPK2 in ESCC specimens, adjacent non-cancerous tissues and cell lines was assessed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR)...
January 2018: Experimental and Therapeutic Medicine
https://www.readbyqxmd.com/read/29430188/lincrna-ror-promotes-metastasis-and-invasion-of-esophageal-squamous-cell-carcinoma-by-regulating-mir-145-fscn1
#17
Muhe Shang, Xianghu Wang, Ying Zhang, Zhikui Gao, Tian Wang, Ran Liu
Background and objective: In an attempt to discover a new biomarker for early diagnosis and prognosis of esophageal squamous cell carcinoma (ESCC), the regulation mechanism of large intergenic non-coding RNA-regulator of reprogramming (lincRNA-ROR) as a microRNA (miRNA) sponge was studied. Patients and methods: ROR expression in 91 pairs of ESCC tissue samples and matched adjacent tissues was quantified with real-time fluorescent quantitative polymerase chain reaction (qRT-PCR)...
2018: OncoTargets and Therapy
https://www.readbyqxmd.com/read/29428966/slc52a3-expression-is-activated-by-nf-%C3%AE%C2%BAb-p65-rel-b-and-serves-as-a-prognostic-biomarker-in-esophageal-cancer
#18
Lin Long, Xiao-Xiao Pang, Fei Lei, Jia-Sheng Zhang, Wei Wang, Lian-Di Liao, Xiu-E Xu, Jian-Zhong He, Jian-Yi Wu, Zhi-Yong Wu, Li-Dong Wang, De-Chen Lin, En-Min Li, Li-Yan Xu
The human riboflavin transporter-3 (encoded by SLC52A3) plays a prominent role in riboflavin absorption. Interestingly, abnormal expression patterns of SLC52A3 in multiple types of human cancers have been recently noted. However, the molecular mechanisms underlying its dysregulation remain unclear. In this study, we find that SLC52A3 has two transcript variants that differ in the transcriptional start site, and encode different proteins: SLC52A3a and SLC52A3b. Importantly, aberrant expressions of SLC52A3 are associated with stepwise development of esophageal squamous cell carcinoma (ESCC) as well as the survival rates of ESCC patients...
February 10, 2018: Cellular and Molecular Life Sciences: CMLS
https://www.readbyqxmd.com/read/29427302/multiple-roles-of-sim2-in-esophageal-squamous-cell-carcinoma-and-its-clinical-implications
#19
Masashi Tamaoki, Rie Komatsuzaki, Masayuki Komatsu, Keiko Minashi, Kazuhiko Aoyagi, Takao Nishimura, Fumiko Chiwaki, Tomoko Hiroki, Hiroyuki Daiko, Kazuhiro Morishita, Yoshiharu Sakai, Hiroshi Seno, Tsutomu Chiba, Manabu Muto, Teruhiko Yoshida, Hiroki Sasaki
The degree of histological differentiation is an important characteristic of cancers and may be associated with their malignant potentials. However, in squamous cell carcinomas, a key transcriptional factor to regulate tumor differentiation is largely unknown. Chemoradiotherapy (CRT) is a standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC); however, the survival rate is still below 40%. From microarray data, SIM2 was overexpressed in the epithelial subtype. Here, we investigated the correlation between SIM2 expression and its clinical implication and in vitro and in vivo functions of SIM2 in tumor differentiation and in CRT sensitivity...
February 10, 2018: Cancer Science
https://www.readbyqxmd.com/read/29426342/dosimetric-comparison-between-proton-beam-therapy-and-photon-radiation-therapy-for-locally-advanced-esophageal-squamous-cell-carcinoma
#20
Yasuhiro Hirano, Masakatsu Onozawa, Hidehiro Hojo, Atsushi Motegi, Sadatomo Zenda, Kenji Hotta, Shunsuke Moriya, Hidenobu Tachibana, Naoki Nakamura, Takashi Kojima, Tetsuo Akimoto
BACKGROUND: The purpose of this study was to perform a dosimetric comparison between proton beam therapy (PBT) and photon radiation therapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC) who were treated with PBT in our institution. In addition, we evaluated the correlation between toxicities and dosimetric parameters, especially the doses to normal lung or heart tissue, to clarify the clinical advantage of PBT over photon radiation therapy. METHODS: A total of 37 consecutive patients with Stage III thoracic ESCC who had received PBT with or without concurrent chemotherapy between October 2012 and December 2015 were evaluated in this study...
February 9, 2018: Radiation Oncology
keyword
keyword
30616
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"